Does Shilajit Interact With Medications?

In short: Taking medication does not automatically mean you cannot take Shilajit. But the absence of a documented interaction does not mean the combination has been proven safe. The sensible question is not "does Shilajit interact with medications?" — it is "what exact medicine, what exact product, what evidence exists, and how serious would incomplete information be?"

Why the yes/no question is the wrong question

When somebody searches "does Shilajit interact with medications?", they are usually asking something more specific: can I add Shilajit to what I already take without interfering with treatment that matters to my health?

Most supplement interaction content answers that question in one of two unhelpful ways. The first produces a long list of medication categories to avoid, as though every combination has been clinically demonstrated to interact. The second says "no interactions are known" and allows the reader to interpret that as proof of safety. Current NHS Specialist Pharmacy Service guidance makes the distinction clearly: no interaction information does not mean an interaction is impossible — it may simply mean the interaction potential is unknown.^[1]

The more accurate starting point is: specific human Shilajit–drug interaction research is limited. That means we should neither assume there is no interaction nor present every theoretical concern as an established warning.

Throughout this article, every medication category is assessed using three questions:

What has actually been demonstrated? Direct human evidence, documented pharmacology or a recognised interaction — stated clearly if it exists.

What is biologically plausible but not clinically established? Where Shilajit has demonstrated physiological effects that could theoretically matter alongside a medicine — labelled as plausible, not proven.

What simply remains unknown? For many combinations, direct clinical interaction research is limited. That should be stated honestly rather than filled with guesswork.

What "interaction" actually means

People often imagine a drug interaction means one substance blocks a liver enzyme that processes a medication. That is one possibility, but not the only one.

Interactions can broadly involve two types. Pharmacokinetic interactions affect how a medicine is absorbed, distributed, metabolised or eliminated — potentially changing how much of the drug reaches the body. Pharmacodynamic interactions occur when two substances influence the same physiological system, so their effects may add together or work against one another. NHS SPS recommends considering both when evaluating complementary products alongside conventional medication.^[1]

For the reader, the practical translation is: sometimes one substance changes how much of a medicine reaches your body; other times both substances act on the same part of physiology and their combined effect differs from either alone.

Risk is also not only about how likely an interaction is. Sometimes the evidence for a Shilajit interaction may be weak, but the consequence of getting the decision wrong could still be serious. That is why the medicine itself — and how much room for error it has — matters as much as the interaction evidence.

Medication categories: evidence summary

Narrow therapeutic index medicines

Some medicines have a very small margin between an effective dose and one associated with toxicity or treatment failure. Current NHS Specialist Pharmacy Service guidance specifically highlights medicines including warfarin, lithium, digoxin and ciclosporin as situations where complementary products deserve particular caution, because even relatively small changes in drug exposure can have clinically important consequences.^[1,2]

I want to be precise about what that means for Shilajit.

Known: these medicines require particularly careful control and monitoring.

Not established: whether Shilajit specifically changes their concentrations or effects in humans.

Practical position: the caution here comes from the medicine, not from a proven Shilajit interaction. When the medicine has so little room for error, uncertainty about an additional complementary product matters more — regardless of whether a specific interaction has been demonstrated.

I would not encourage somebody taking one of these medicines to add Shilajit without their pharmacist or prescribing clinician specifically reviewing the complete product formulation first.

Blood-pressure medicines

This category appears on almost every Shilajit interaction list — often with the warning that Shilajit lowers blood pressure and could therefore cause dangerously low blood pressure when combined with antihypertensive medication. The available human evidence does not support that chain of reasoning.

A 2023 randomised study involved 60 older people with hypertension. The intervention group received purified Shilajit 500 mg twice daily alongside their existing antihypertensive treatment for 30 days. The study reported favourable changes in oxidative-stress markers but did not find significant changes in arterial stiffness or endothelial function, and no adverse interaction with antihypertensive treatment was reported.^[3] An earlier study in healthy volunteers taking Shilajit for 45 days also reported no significant change in blood pressure or pulse rate.^[4]

Known: Shilajit has been given alongside antihypertensive treatment in a small human study without an obvious interaction signal — though that study was not designed as a comprehensive drug-interaction trial.

Not established: that Shilajit produces a clinically meaningful additive hypotensive effect with blood-pressure medication.

Practical position: check before combining, but do not assume the combination is automatically dangerous based on theoretical reasoning alone.

Glucose-lowering medicines

"Shilajit may lower blood sugar" is repeated widely online. The direct human evidence is much weaker than the warning often suggests.

A human skeletal-muscle study gave purified Shilajit at 250 mg twice daily for eight weeks and specifically reported no change in blood glucose during supplementation.^[5] Research involving Ayurvedic combinations containing Shilajit in people with type 2 diabetes used multi-ingredient formulations, so any glucose change cannot reasonably be attributed to Shilajit alone.

Known: robust human evidence showing Shilajit alone substantially lowers blood glucose is limited, and at least one human supplementation study found no change.

Theoretically possible: if a Shilajit preparation influenced glucose regulation, combining that effect with glucose-lowering medication could matter.

Practical position: medicines such as insulin and some other glucose-lowering therapies can themselves produce clinically important hypoglycaemia, so uncertainty deserves more attention in somebody whose glucose is actively being pharmacologically controlled. Check before combining — but do not present this as a proven interaction.

Hormonal and endocrine treatment

This is one of the more biologically grounded areas of caution — because here we actually have a human physiological signal from Shilajit itself.

A randomised, double-blind, placebo-controlled trial in healthy men aged 45–55 found that purified Shilajit at 250 mg twice daily for 90 days increased total testosterone, free testosterone and DHEAS compared with placebo.^[6] A separate study in men with oligospermia also reported changes involving testosterone and FSH.^[7]

Known: Shilajit has altered particular androgenic hormone measurements in human studies.

Unknown: whether it meaningfully interacts with testosterone replacement, anti-androgen therapy, fertility medicines, HRT or other hormonal treatments.

Theoretically possible: where a medicine is deliberately manipulating the same endocrine system, an additional substance with demonstrated hormonal effects could complicate treatment or interpretation of laboratory results.

Practical position: individual clinical review is appropriate. Do not jump from the testosterone trial to claiming Shilajit interferes with the contraceptive pill, HRT or every endocrine medication — we do not have evidence for that.

Anticoagulants and antiplatelets

Supplement websites very often describe Shilajit as a "blood thinner." I do not want us repeating that claim, because I have not found good direct human evidence demonstrating that oral Shilajit produces a clinically meaningful anticoagulant or antiplatelet effect.

There is research on individual compounds such as shikimic acid showing antiplatelet effects under experimental conditions, including ex-vivo human platelet work.^[8] But finding a compound associated with natural materials and demonstrating an effect at a particular experimental concentration does not automatically establish that a finished Shilajit product changes bleeding risk in humans. Those are different claims.

Known: a Shilajit-specific anticoagulant interaction has not been established in human research.

Theoretically possible: biological speculation exists around some constituents, but that is not the same as demonstrating a clinical bleeding interaction.

Practical position: anticoagulant treatment — including apixaban, rivaroxaban, dabigatran, edoxaban, clopidogrel and therapeutic aspirin — is high-stakes. Either excessive or insufficient anticoagulation can have serious consequences. Someone taking these medicines should have the complete product reviewed by a pharmacist or clinician rather than relying on a generic internet interaction list. Warfarin also falls within the narrow-therapeutic-index category, where NHS SPS recommends particular caution with complementary products.^[1,2]

That is very different from saying Shilajit definitely thins your blood.

Cancer and immunosuppressive treatment

I include this as a high-consequence uncertainty category — not because a specific Shilajit interaction with cancer treatment has been demonstrated, but because the consequences of treatment interference can be serious and the direct research is inadequate.

Cancer treatment can involve medicines with narrow dosing margins, complex metabolism, hormonal actions or treatment strategies where unplanned supplementation could potentially interfere with effectiveness or toxicity. UK NHS cancer services advise considerable caution with herbal and dietary supplements during active anti-cancer treatment because interaction evidence is often incomplete.^[9]

Known: there is inadequate direct clinical research establishing the safety of combining Shilajit with the many different anti-cancer treatments.

Practical position: someone undergoing chemotherapy, immunotherapy, targeted therapy or other active anti-cancer treatment should not add Shilajit independently. The oncology pharmacist or clinical team should review the exact product. The same applies to specialist immunosuppressive medicines — ciclosporin is already included among the narrow-therapeutic-index medicines for which NHS SPS recommends particular caution.^[1]

Uric acid, gout, allopurinol and febuxostat

Shilajit is sometimes listed as unsuitable for people with gout or high uric acid — but the human evidence behind the claim that purified Shilajit raises serum urate is weak.

A small human study in healthy volunteers administered Shilajit for 45 days and assessed numerous blood-chemistry and safety measures without identifying a uric-acid signal.^[4] A 90-day study of processed Shilajit in men with oligospermia reported unchanged hepatic and renal safety parameters, with subsequent reporting specifically noting that serum uric acid was not significantly altered.^[7]

Known: robust human evidence showing purified Shilajit raises serum uric acid is not currently available.

Not established: whether adding Shilajit affects urate control, gout-flare frequency or urate-lowering treatment in people with established gout.

Practical position for allopurinol and febuxostat: specific interaction not established. Check before combining because serum urate is already being deliberately controlled — not because we have demonstrated that Shilajit interferes with these medicines.

Gout should be treated as a situation requiring individual review rather than as a proven Shilajit contraindication. If your uric acid is being actively managed with medication, check before introducing Shilajit and do not alter prescribed treatment in order to accommodate the supplement. If you are experiencing repeated flares or your treatment is being adjusted, this is not the right time to introduce a new variable.

Important: do not use Shilajit as a replacement for prescribed urate-lowering therapy. Shilajit has not been established as a treatment for gout or hyperuricaemia. If you believe Shilajit is affecting your uric acid or gout symptoms, tell your clinician rather than adjusting your prescription independently.

Liver safety

I want to address liver safety without creating the impression that Shilajit is a known hepatotoxic supplement — because the available human evidence does not support that description.

In a 90-day study of processed Shilajit in men with oligospermia, researchers assessed hepatic safety parameters including bilirubin, ALT, AST and alkaline phosphatase. These remained unaltered during supplementation.^[7] A separate 90-day testosterone study reported similar findings.^[6] That is reassuring evidence within those specific studies — but it does not establish that Shilajit is risk-free for every person, particularly because people with significant liver disease have not been studied adequately.

There is also animal research investigating possible hepatoprotective effects of Shilajit in rat models.^[10] That is interesting preclinical research. It does not justify telling somebody taking a medicine with recognised liver risks that Shilajit will protect them. Animal hepatoprotective findings are not evidence that Shilajit treats human liver disease or prevents medication-induced liver injury.

If you have diagnosed liver disease, persistently abnormal liver blood tests, or a prescription that requires hepatic monitoring: Shilajit deserves individual review before it is added. That is not because a Shilajit–liver interaction has been proven. It is because the clinical situation is already one where additional uncertainty matters.

If your clinician is already monitoring liver-related measurements, make sure they know about any Shilajit product you are taking — particularly if the medicine is new, the dose is being adjusted, or liver tests are already abnormal. This is not about inventing an interaction. It is about giving the person interpreting your results an accurate picture of everything you are taking.

Heavy metals and contaminants

Heavy metals are one of the most legitimate questions somebody can ask about Shilajit — but they should not be confused with a drug interaction. They are primarily a product-quality question.

Shilajit comes from a complex geological environment, so elemental composition is part of the material. A 2026 analysis of 12 Shilajit samples from different geographical origins found substantial variation in mineral and elemental composition, including essential elements as well as potentially toxic elements such as lead, cadmium and mercury. In the samples analysed, the toxic metals were below the toxicity thresholds used by the researchers, and geochemical patterns suggested some elements were naturally associated with the geological material rather than representing external contamination.^[11]

But product variability means testing still matters. A 2025 analysis investigated thallium in natural Shilajit and commercial Shilajit supplements, detecting thallium in both — with concentrations in some commercial supplements higher than in the crude Shilajit samples examined. The authors called for regular monitoring and standardised testing.^[12]

The relevant question is therefore not simply whether a metal can be detected, but how much is present in the finished product and whether appropriate purification and analytical testing are in place. Himalayan origin does not make testing unnecessary. A natural mineral-rich substance can vary according to local geology, source and processing.

For someone taking medication, this matters because a meaningful interaction assessment starts with knowing what product is actually being consumed. Independent testing helps answer questions about composition and contaminants — it does not prove that a product is compatible with every prescription. Those are different questions.

A contaminated supplement creates a different concern from a drug interaction. A genuine drug interaction involves one substance affecting the pharmacology of another. Contaminant exposure creates a separate toxicological issue. Both matter — but they should not be presented as the same thing.

Pregnancy and breastfeeding

The human Shilajit research we have involves healthy men, men with oligospermia, recreationally active adults and postmenopausal women. We do not have good pregnancy-specific or breastfeeding-specific human studies establishing safe dosing, fetal exposure, placental transfer, transfer into breast milk or effects on a breastfed infant.

Respecting Shilajit's traditional Rasayana use does not change this position. Traditional use and modern reproductive-safety assessment answer different questions. Independent testing can tell us about composition and contaminants — it cannot establish whether repeated exposure to Shilajit's constituents is appropriate for a developing fetus or breastfeeding infant.

If you are pregnant or breastfeeding and are already taking prescribed medicine, our Shilajit guidance should never encourage you to reduce, delay or stop that medication. The prescription treats a medical need. Shilajit is the optional component. If there is uncertainty, Shilajit is the part of the routine that can be reconsidered.

Practical decision process

By this point you have read about known versus theoretical interactions, high-risk medicines, pregnancy, gout, liver considerations and product quality. The question now is: what do I actually do?

The central principle is: do not decide whether Shilajit belongs alongside your medication from a generic interaction list. Identify the exact medicine, the exact Shilajit product and your own clinical circumstances, then assess the combination. This closely reflects the current NHS SPS approach to complementary products.^[1,2]

Shilajit Gold+ by 5 Rivers Nutrition

If you are assessing Shilajit alongside medication, the interaction question should be about the complete product you intend to take — not a generic internet concept of Shilajit.

Shilajit Gold+ is not simply isolated Shilajit. The capsule and resin formats contain different combinations of Ayurvedic ingredients alongside Shilajit, so the full label, serving and format should be considered when checking compatibility with a prescription. This is consistent with NHS medicines guidance, which recommends reviewing every ingredient in a complementary product rather than relying on its headline name alone.^[1]

We independently test Shilajit Gold+ batches through Eurofins, including heavy-metal screening for arsenic, cadmium, lead and mercury, and fulvic-acid composition. That testing tells us something valuable about product quality and contaminant control. It does not prove that Gold+ is compatible with every medicine — those are different questions, and we would not claim otherwise.

The responsible promise we make is transparency: the complete ingredient list, amounts per serving, format differences and available quality testing are accessible so that customers and healthcare professionals can make a better-informed decision. If your treatment carries significant interaction risk, requires close monitoring, or your pharmacist cannot confidently assess the combination, protecting the prescribed treatment comes first.

We would rather help you decide Gold+ is not appropriate for you right now than pretend every customer should take it. Shilajit Gold+ should never require you to gamble with treatment you depend on.

Key takeaways

Frequently asked questions

Does Shilajit interact with blood-pressure medication?

A small human study gave purified Shilajit alongside existing antihypertensive treatment for 30 days without reporting an obvious interaction signal. A separate study in healthy volunteers found no significant change in blood pressure during Shilajit supplementation. An additive hypotensive interaction has not been established. Check before combining, but do not assume the combination is automatically dangerous based on theoretical reasoning alone.

Can I take Shilajit with warfarin?

Warfarin has a narrow therapeutic index — very small changes in drug exposure can have clinically important consequences. NHS SPS recommends particular caution with complementary products in people taking narrow-therapeutic-index medicines. A specific Shilajit–warfarin interaction has not been established, but the caution comes from the medicine itself. Have the complete Gold+ formulation reviewed by your anticoagulation pharmacist or clinician before combining.

Does Shilajit raise uric acid or worsen gout?

The human evidence that purified Shilajit raises serum uric acid is weak. Small human studies have not shown a clear uric-acid signal. What we do not have are good clinical trials specifically testing Shilajit in people with gout or alongside urate-lowering medicines such as allopurinol or febuxostat. Treat gout as a situation requiring individual review rather than a proven contraindication.

Is Shilajit safe with diabetes medication?

Robust human evidence showing Shilajit alone substantially lowers blood glucose is limited, and at least one human supplementation study found no change in glucose. The concern about additive hypoglycaemia is largely theoretical. However, medicines such as insulin can themselves produce clinically important hypoglycaemia, so uncertainty deserves more attention when glucose is actively being pharmacologically controlled. Check before combining.

Can I take Shilajit during pregnancy?

No. 5 Rivers Nutrition does not recommend Shilajit Gold+ during pregnancy because there is not enough pregnancy-specific human research to establish its safety for the mother or developing baby. This is a precaution based on insufficient evidence, not evidence of proven harm. If you have already taken Shilajit before discovering you are pregnant, pause further use and discuss the complete product with your midwife, pharmacist or doctor.

Does Shilajit affect hormonal medication?

Human Shilajit trials have reported increases in testosterone and DHEAS. That makes hormonal therapies a more biologically grounded area of caution than some generic warnings. However, a specific drug interaction with testosterone replacement, anti-androgen therapy, HRT, fertility medicines or the contraceptive pill has not been established. Individual clinical review is appropriate before combining Shilajit with any hormonal treatment.

Is Shilajit safe with cancer treatment?

There is inadequate direct clinical research establishing the safety of combining Shilajit with anti-cancer treatments. Cancer medicines can have narrow dosing margins and complex pharmacology. Someone undergoing chemotherapy, immunotherapy or other active anti-cancer treatment should not add Shilajit independently — the oncology pharmacist or clinical team should review the exact product.

What should I tell my pharmacist when asking about Shilajit and my medication?

Bring the product name, complete ingredient list, amount per serving and intended daily serving — not just the word "Shilajit". Also be ready to confirm which medicine you take, the dose, what it is treating and whether it requires monitoring. The more specific the information, the more useful the assessment can be.

References

[1] NHS Specialist Pharmacy Service. Managing complementary products and conventional medicines. Updated 16 July 2026. Stepwise guidance covering individual circumstances, conventional medicines, exact complementary-product formulation, interaction evidence and monitoring
[2] NHS Specialist Pharmacy Service. Advising on complementary products and conventional medicines. Updated 1 December 2025. Guidance on high-risk medicines, narrow therapeutic index, high-risk conditions and protecting conventional treatment
[3] Patil SG, Patil KA, Sarashetti R, Hadimur K. Effect of purified Shilajit on oxidative stress, arterial stiffness and endothelial function in elderly with hypertension. Indian Journal of Physiology and Pharmacology. 2023;67:197–204
[4] Sharma P, Jha J, Shrinivas V, et al. Shilajit: evaluation of its effects on blood chemistry of normal human subjects. Ancient Science of Life. 2003;23(2):114–119
[5] Das A, Datta S, Rhea B, et al. The Human Skeletal Muscle Transcriptome in Response to Oral Shilajit Supplementation. Journal of Medicinal Food. 2016;19(7):701–709
[6] Pandit S, Biswas S, Jana U, et al. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016;48(5):570–575
[7] Biswas TK, Pandit S, Mondal S, et al. Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia. Andrologia. 2010;42(1):48–56
[8] Huang F, Xiu Q, Sun J, Hong E. Anti-platelet and anti-thrombotic effects of triacetylshikimic acid in rats. Journal of Cardiovascular Pharmacology. 2002;39(2):262–270. Mechanistic compound research — not evidence of a clinical Shilajit–anticoagulant interaction
[9] Leeds Teaching Hospitals NHS Trust. Cancer and dietary supplements / herbal remedies. Current NHS patient guidance on supplementation during cancer treatment
[10] Nikfallah A, Saghafi S, Mohammadi E, et al. Hepatoprotective effects of Shilajit on high fat-diet induced non-alcoholic fatty liver disease in rats. Preclinical animal research
[11] Kamgar E, Angaïts A, Zembrzuska J, et al. Characterization of metal composition and molecular weight distribution in Shilajit. Journal of Trace Elements in Medicine and Biology. 2026;96:127913
[12] Kamgar E, Zembrzuska J, Zembrzuski W, Kaykhaii M. Quantifying of thallium in Shilajit and its supplements to unveil the potential risk of consumption of this popular traditional medicine. BMC Chemistry. 2025;19:20
[13] NHS. Herbal medicines and complementary therapies. Current guidance advising people taking medicines to check with a pharmacist before adding herbal/complementary products
[14] Stohs SJ. Safety and efficacy of shilajit (mumie, moomiyo). Phytotherapy Research. 2014;28(4):475–479

---

There is no single yes-or-no answer to whether Shilajit interacts with medication. Some combinations have stronger reasons for caution than others, while many have simply not been studied directly. The responsible approach is to distinguish what is known, what is biologically plausible and what remains uncertain — then consider how much that uncertainty matters for the medicine and the person taking it.

Shilajit Gold+ should never require you to gamble with treatment you depend on. If the combination can be assessed reasonably and is considered appropriate, Shilajit may still have a place in your routine. If the medicine is high-risk, your circumstances are complex or the interaction cannot be assessed confidently, protecting the prescription comes first. Sometimes the responsible answer is simply: not now.

---